{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:08:49Z","timestamp":1785298129966,"version":"3.55.0"},"reference-count":58,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"Inova Fiocruz"},{"DOI":"10.13039\/501100003593","name":"MCTI | Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2020,9,21]]},"abstract":"<jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is already responsible for far more deaths than previous pathogenic coronaviruses (CoVs) from 2002 and 2012. The identification of clinically approved drugs to be repurposed to combat 2019 CoV disease (COVID-19) would allow the rapid implementation of potentially life-saving procedures. The major protease (Mpro) of SARS-CoV-2 is considered a promising target, based on previous results from related CoVs with lopinavir (LPV), an HIV protease inhibitor.<\/jats:p>","DOI":"10.1128\/aac.00825-20","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T09:49:47Z","timestamp":1596707387000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":101,"title":["Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production"],"prefix":"10.1128","volume":"64","author":[{"given":"Natalia","family":"Fintelman-Rodrigues","sequence":"first","affiliation":[{"name":"Laborat\u00f3rio de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil"},{"name":"National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT\/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Q.","family":"Sacramento","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil"},{"name":"National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT\/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlyle","family":"Ribeiro Lima","sequence":"additional","affiliation":[{"name":"National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT\/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Souza da Silva","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Biologia Molecular e Doen\u00e7as End\u00eamicas, IOC, Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"},{"name":"National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT\/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 C.","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil"},{"name":"Universidade Igua\u00e7u, Nova Igua\u00e7u, Rio de Janeiro, Brazil"},{"name":"National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT\/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayara","family":"Mattos","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil"},{"name":"National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT\/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline S.","family":"de Freitas","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil"},{"name":"National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT\/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius","family":"Cardoso Soares","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suelen","family":"da Silva Gomes Dias","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo R.","family":"Temerozo","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Pesquisas sobre o Timo, IOC, Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"},{"name":"National Institute for Science and Technology on Neuroimmunomodulation (INCT\/NIM), IOC, Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0037-059X","authenticated-orcid":false,"given":"Milene D.","family":"Miranda","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de V\u00edrus Respirat\u00f3rio e do Sarampo, IOC, Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline R.","family":"Matos","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de V\u00edrus Respirat\u00f3rio e do Sarampo, IOC, Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando A.","family":"Bozza","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"},{"name":"Instituto D\u2019or de Pesquisa e Ensino, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Carels","sequence":"additional","affiliation":[{"name":"National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT\/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Roberto","family":"Alves","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Biologia Molecular e Doen\u00e7as End\u00eamicas, IOC, Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilda M.","family":"Siqueira","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de V\u00edrus Respirat\u00f3rio e do Sarampo, IOC, Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8349-9529","authenticated-orcid":false,"given":"Patr\u00edcia T.","family":"Bozza","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2212-3899","authenticated-orcid":false,"given":"Thiago Moreno L.","family":"Souza","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil"},{"name":"National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT\/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(06)66005-3"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0118-9"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2169-0"},{"key":"e_1_3_3_5_2","unstructured":"World Health Organization. 2020. Middle east respiratory syndrome coronavirus (MERS-CoV). https:\/\/www.who.int\/emergencies\/mers-cov\/en\/. Accessed 24 July 2020."},{"key":"e_1_3_3_6_2","unstructured":"World Health Organization. 2020. Severe acute respiratory syndrome (SARS). https:\/\/www.who.int\/health-topics\/severe-acute-respiratory-syndrome. Accessed 24 July 2020."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30120-1"},{"key":"e_1_3_3_8_2","unstructured":"Romer P Garber AM. 2020. Opinion. Will our economy die from coronavirus? The New York Times. https:\/\/www.nytimes.com\/2020\/03\/23\/opinion\/coronavirus-depression.html. Accessed 24 July 2020."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/d41587-020-00003-1"},{"key":"e_1_3_3_10_2","unstructured":"World Health Organization. 2020. WHO R&D Blueprint: informal consultation on prioritization of candidate therapeutic agents for use in novel coronavirus 2019 infection Geneva Switzerland WHO\/HEO\/R&D Blueprint (nCoV)\/2020.1. https:\/\/apps.who.int\/iris\/handle\/10665\/330680. Accessed 24 July 2020."},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.8857"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00102-15"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0403596101"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-2438-7_1"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2019.1604685"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832ba904"},{"key":"e_1_3_3_18_2","first-page":"31S","article-title":"Treatment guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents: an update","volume":"33","author":"Gibert CL","year":"2016","unstructured":"Gibert CL. 2016. Treatment guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents: an update. Fed Pract 33:31S\u201336S.","journal-title":"Fed Pract"},{"key":"e_1_3_3_19_2","unstructured":"Dayer MR. 2020. Old drugs for newly emerging viral disease COVID-19: bioinformatic prospective. arXiv 2003.04524 [q-bio.BM] https:\/\/arxiv.org\/abs\/2003.04524."},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00267-13"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12871"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0282-0"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-016-0558-0"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00125-0"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007072"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01389-18"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09797-8"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep40920"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027207"},{"key":"e_1_3_3_31_2","unstructured":"Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial on lopinavir-ritonavir. 2020. No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY. https:\/\/www.recoverytrial.net\/news\/no-clinical-benefit-from-use-of-lopinavir-ritonavir-in-hospitalised-covid-19-patients-studied-in-recovery. Accessed 24 July 2020."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31042-4"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2020.03.007"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13940-6"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.2147\/HIV.S79956"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2011.06.032"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2020.03.025"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1835675100"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cplett.2020.137489"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.06.023"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0171-2985(11)80365-7"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-017-0629-x"},{"key":"e_1_3_3_43_2","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed LJ","year":"1938","unstructured":"Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am J Hyg 27:493\u2013497.","journal-title":"Am J Hyg"},{"key":"e_1_3_3_44_2","volume-title":"Coronavirus disease 2019 (COVID-19)","author":"CDC","year":"2020","unstructured":"CDC. 2020. Coronavirus disease 2019 (COVID-19). CDC, Atlanta, GA."},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.10128"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20035"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.23905"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2223-y"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20084"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20289"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0282(2000)56:4<257::AID-BIP10029>3.0.CO;2-W"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpcb.5b03381"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1063\/1.4926535"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1208351"},{"key":"e_1_3_3_55_2","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen WL","year":"1998","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. 1998. Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926.","journal-title":"J Chem Phys"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1063\/1.464397"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(80)90338-3"},{"key":"e_1_3_3_58_2","first-page":"167","article-title":"Heterogeneity of cysteine proteinases in Leishmania braziliensis and Leishmania major","volume":"26","author":"Alves CR","year":"1993","unstructured":"Alves CR, Marzochi MC, Giovanni-de-Simone S. 1993. Heterogeneity of cysteine proteinases in Leishmania braziliensis and Leishmania major. Braz J Med Biol Res 26:167\u2013171.","journal-title":"Braz J Med Biol Res"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-010-0716-y"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00825-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00825-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:34:52Z","timestamp":1645468492000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00825-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,9,21]]}},"alternative-id":["10.1128\/AAC.00825-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.00825-20","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.04.020925","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"2020-04-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00825-20"}}